PSIAC
Sad Pill Bild Bildrechte: © spinetta / Fotolia

Oops!

Sie verwenden eine veraltete Version Ihres Internetbrowsers und können nicht auf die Inhalte der Seite zugreifen.
Bitte aktualisieren Sie Ihre Browserversion.

PSIAC

Literaturverzeichnis

Erweiterte Suche
Zhou HH. Clin Pharmacol Ther. Jun 1990; 47(6): 686-93 Pubmed [4184]
Zhou L. Biopharm Drug Dispos. May 2010; 31(4): 228-42 Pubmed, Volltext, DOI [7560]
Zhou R. Med Sci Monit. Dec 2021; 27: e934043 Pubmed [12118]
Zhou S. Clin Pharmacokinet. Jan 2005; 44(3): 279-304 Pubmed [5847]
Zhou SF. Clin Pharmacokinet. Jan 2009; 48(12): 761-804 Pubmed [125]
Zhou SF. Curr Drug Metab. Jun 2008; 9(5): 394-409 Pubmed [2850]
Zhou SF. Curr Drug Metab. May 2008; 9(4): 310-22 Pubmed [6402]
Zhou SF. Curr Med Chem. Jan 2009; 16(27): 3480-675 Pubmed [2113]
Zhou SF. Ther Drug Monit. Dec 2007; 29(6): 687-710 Pubmed [2650]
Zhou T. Exp Ther Med. Mar 2019; 17(3): 1625-1630 Pubmed, Volltext, DOI [9952]
Zhou W. Clin Pharmacol Ther. Jul 2018; 104(1): 188-200 Pubmed [7714]
Zhou WJ. Br J Pharmacol. Jul 2012; 166(5): 1669-83 Pubmed, Volltext, DOI [4404]
Zhou XJ. Antimicrob Agents Chemother. Jul 2006; 50(7): 2309-15 Pubmed, Volltext, DOI [7083]
Zhou YT. Ther Clin Risk Manag. Jan 2014; 10: 17-26 Pubmed, Volltext, DOI [4146]
Zhou-Pan XR. Cancer Res. Nov 1993; 53(21): 5121-6 Pubmed [4835]
Zhu J. Free Radic Biol Med. Apr 2019; 134: 9-22 Pubmed [10687]
Zhu L. Antivir Ther. Jan 2010; 15(8): 1107-14 Pubmed [9375]
Zhu M. Antimicrob Agents Chemother. Jun 2009; 53(6): 2346-53 Pubmed, Volltext, DOI [3039]
Zhu XQ. J Clin Pharm Ther. Feb 2018; 43(1): 141-144 Pubmed [7312]
Zhu Y. ACS Med Chem Lett. Sep 2012; 3(10): 844-9 Pubmed, Volltext, DOI [8170]
Zhu Y. Drug Metab Dispos. Feb 2014; 42(2): 245-9 Pubmed [10192]
Zhuo C. Sci Rep. Apr 2017; 8: 45865 Pubmed, Volltext, Nature [7767]
Ziegler D. Diabetes Metab Res Rev. May 2008; 24 Suppl 1: S52-7 Pubmed [11555]
Ziegler M. Mov Disord. Apr 2003; 18(4): 418-25 Pubmed [10436]
Ziemssen T. JMIR Res Protoc. Jul 2020; 9(7): e19598 Pubmed, Volltext, DOI [10017]
Zientek M. J Pharmacol Toxicol Methods. Nov 2008; 58(3): 206-14 Pubmed [10569]
Ziffra M. Ann Clin Psychiatry. May 2021; 33(2): 124-133 Pubmed [12124]
Zilly W. Clin Pharmacokinet. Jan 1977; 2(1): 61-70 Pubmed [6261]
Zilly W. Verh Dtsch Ges Inn Med. Jan 1974; 80: 1538-40 Pubmed [5767]
Zimbron J. Eur Neuropsychopharmacol. Sep 2016; 26(9): 1353-1365 Pubmed [7992]
Zimmer R. Acta Psychiatr Scand Suppl. Jan 1990; 360: 84-6 Pubmed [1926]
Zimmerman HJ. Hepatology. Sep 1995; 22(3): 767-73 Pubmed [3503]
Zimmerman JJ. AAPS J. Oct 2004; 6(4): e28 Pubmed, Volltext, DOI [6225]
Zimmerman JJ. Pharmacotherapy. Jul 2008; 28(7): 895-905 Pubmed [7318]
Zimmerman T. Clin Neuropharmacol. Apr 1991; 14(2): 165-9 Pubmed [10968]
Zimmermann AE. Clin Infect Dis. Jan 2006; 42(2): 283-90 Pubmed [5687]
Zini R. Int J Clin Pharmacol Ther Toxicol. Feb 1991; 29(2): 64-6 Pubmed [10049]
Zink M. Pharmacopsychiatry. May 2006; 39(3): 109-11 Pubmed [10487]
Zirkle GA, King PD, McAtee OB, Van Dyke R. Effects of chlorpromazine and alcohol on coordination and judgment. JAMA (1959) 171, 1496-9 [817]
Zirwas MJ. Dermatitis. Dec 2006; 17(4): 208-10 Pubmed [8917]
Zisook S. Biol Psychiatry. Feb 2006; 59(3): 203-10 Pubmed [8405]
Zitelli BJ. Clin Pediatr (Phila). Mar 1987; 26(3): 117-9 Pubmed [5863]
Zitron E. Circulation. Feb 2005; 111(7): 835-8 Pubmed [11682]
Zo'o M. Pediatr Radiol. Nov 2011; 41(11): 1393-400 Pubmed, Volltext, Springer [4918]
Zoccali et al. (2007) J Clin Psychopharmacol 93:109-116 [1144]
Zoccali R. Pharmacol Res. Oct 2003; 48(4): 411-4 Pubmed [2545]
Zoleptil (Zotepine) Knoll Limited . Summary of product characteristics, Novembet 2001 [2504]
Zoleptil (Zotepine) Knoll Limited . Summary of product characteristics. November 2001 [2078]
Zoleptil (Zotepine) Knoll Limited . Summary of product characteristics., November 2001 [1646]
Zoleptil (Zotepine) Knoll Limited . Summary of product characteristics., Novembet 2001 [945]
Zoleptil (Zotepine). Knoll Limited. Summary of product characteristics, November 2001 [2515]
Zomorodi K. Clin Pharmacol Drug Dev. Apr 2021; 10(4): 404-413 Pubmed, Volltext, DOI [10296]
Zong J. J Int AIDS Soc. Nov 2014; 17(4 Suppl 3): 19584 Pubmed, Volltext, DOI [6639]
Zor M. Int Urogynecol J. Jul 2015; 26(7): 959-66 Pubmed [8295]
Zoungas S. Diabetes Obes Metab. Apr 2020; 22 Suppl 2: 5-11 Pubmed [11786]
Zubieta, Demitrack. J Clin Pharmacol (1991) 11, 327-328 [1336]
Zubillaga I. Endocrinol Diabetes Nutr. Jan 2017; 64(6): 338-339 Pubmed [6373]
Zuchora B. Eur Neuropsychopharmacol. Jan 2005; 15(1): 85-93 Pubmed [9712]
Zullino DF. Br J Clin Pharmacol. Jan 2005; 59(1): 118-9; author reply 119 Pubmed [10815]
Zullino DF. Drugs Today (Barc). Jul 2004; 40(7): 603-19 Pubmed [4174]
Zullino DF. Int Clin Psychopharmacol. May 2002; 17(3): 141-3 Pubmed [1193]
Zumoff B. JAMA. May 1977; 237(18): 1960-1 Pubmed [792]
Zung S. Braz J Psychiatry. Mar 2006; 28(1): 84-5 Pubmed [8639]
Zuo R. Drug Metab Dispos. Feb 2017; 45(2): 198-207 Pubmed, Volltext, DOI [7586]
Zuo XC. Drug Metab Pharmacokinet. Jan 2014; 29(4): 305-11 Pubmed [10194]
Zusammenfassung der zur Zulassung eingereichten Klinischen Studien: ZHANG, J: FDA Clinical Review of Olanzapine Pamoate Depot in the Treatment of Schizophrenie: http://www.fda.gov/ohrms/dockets/AC/08/slides/2008-4338s1-01-FDA-Zhang_files/frames.htm [3029]
Zwanzger P. J Clin Psychiatry. Mar 2001; 62(3): 208-9 Pubmed [1672]
Zwanzger P. Nervenarzt. May 2021; 92(5): 433-440 Pubmed [12421]
Zweers-Zeilmaker WM. Xenobiotica. Aug 1997; 27(8): 769-80 Pubmed [4510]
Zylber-Katz E. Ann Pharmacother. Feb 1995; 29(2): 127-31 Pubmed [6005]
Zylber-Katz E. Drug Intell Clin Pharm. Jun 1988; 22(6): 504-5 Pubmed [5573]